Integrated BioPharma (OTCMKTS:INBP) Issues Earnings Results

Integrated BioPharma (OTCMKTS:INBP) released its earnings results on Friday. The company reported ($0.03) EPS for the quarter, Zacks reports. Integrated BioPharma had a negative return on equity of 1.02% and a negative net margin of 0.40%.The firm had revenue of $10.11 million for the quarter.

Integrated BioPharma Price Performance

Integrated BioPharma stock opened at $0.25 on Friday. The company has a market cap of $7.75 million, a price-to-earnings ratio of -3.57 and a beta of 0.41. The firm’s fifty day moving average is $0.28 and its 200 day moving average is $0.31. Integrated BioPharma has a 52-week low of $0.21 and a 52-week high of $0.42.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.